1994
DOI: 10.4269/ajtmh.1994.50.641
|View full text |Cite
|
Sign up to set email alerts
|

Proguanil Plus Sulfamethoxazole is not Causally Prophylactic in the Macaca mulatta—Plasmodium cynomolgi Model

Abstract: Abstract.New drugs for causal prophylaxis of malaria are needed. A proguan il/sulfamethoxazole combination was investigated using a rhesus monkey model (Macaca mulaiia infected with Plasmodium cynomolgi) to determine whether causal prophylaxis could be achieved. When a five-day regimen of proguanil (40 mg/kg/day) combined with sulfamethoxazole (100 mg/kg/day) was used, infection of all animals (6 of 6) was observed, with an extended prepatent period (median 40 days). Two control animals became infected on days… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
3
0

Year Published

1994
1994
2014
2014

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 10 publications
(5 citation statements)
references
References 0 publications
2
3
0
Order By: Relevance
“…Also, these data are consistent with our previous report that TMP-SMX delays liver stage parasite development in rodent malarias and in P. falciparum in vitro [2], [4], and other antifolates have such activity against P. falciparum in vivo [20], [21]. Delayed development of Plasmodium liver stages in vitro and in vivo has been observed with other antifolates, specifically, with P. knowlesi and P.cynomolgi [18], [22], [23], a Plasmodium which is studied experimentally in rhesus macaques also. It is likely that transmission intensity, as well as antifolate resistance, may contribute to the degree to which TMP-SMX reduces liver stage malaria burden in the field.…”
Section: Discussionsupporting
confidence: 92%
“…Also, these data are consistent with our previous report that TMP-SMX delays liver stage parasite development in rodent malarias and in P. falciparum in vitro [2], [4], and other antifolates have such activity against P. falciparum in vivo [20], [21]. Delayed development of Plasmodium liver stages in vitro and in vivo has been observed with other antifolates, specifically, with P. knowlesi and P.cynomolgi [18], [22], [23], a Plasmodium which is studied experimentally in rhesus macaques also. It is likely that transmission intensity, as well as antifolate resistance, may contribute to the degree to which TMP-SMX reduces liver stage malaria burden in the field.…”
Section: Discussionsupporting
confidence: 92%
“…If hypnozoites are spared, however, which they have been shown to be with pyrimethamine and proguanil with P. cynomolgi in vivo , primary parasitemia itself could be delayed and relapses still occur. These antifolates have also been shown to kill the exoerythrocytic stages of P. cynomolgi and P. knowlesi in vitro [40] , [44] [48] , all consistent with what we observed. Trimethoprim alone, and at a much higher dose (50 mg/kg BID compared to the 4 mg/kg BID we used) has been shown to have no anti-hypnozoite effect, nor an effect on delaying primary parasitemia, when used in combination with sub-therapeutic doses of primaquine [48] .…”
Section: Discussionsupporting
confidence: 91%
“…An increase in the time to detection of parasites in the presumed first and second relapses as detected by smear were each used to deduce liver stage reductions, and appearance of parasites after treatment with quinine and quinidine were considered relapses, as previously described [20] , [23] . Study outcomes are presented as Kaplan-Meier survival curves, and statistics are descriptive [40] .…”
Section: Methodsmentioning
confidence: 99%
“…Proguanil (PROG) and cycloguanil (CYC) were measured by ion-paired high-performance liquid chromatography (h.p.l.c.) [9]. The inter-and intraassay coefficients of variation for both PROG and CYC at 10 ng ml-' were less than 10% (n = 6).…”
Section: Methodsmentioning
confidence: 87%